RTRooban Thavarajah

Rooban Thavarajah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rooban Thavarajah has a total of 104 co-authors. Here are the top co-authors by number of shared publications:

  • Elizabeth Joshua

    Department of Oral Pathology, Ragas Dental College and Hospital, Affiliated to the Tamil Nadu Dr. MGR Medical University, Chennai, Tamil Nadu, India

    22 shared publications
  • Kannan Ranganathan

    Department of Oral and Maxillofacial Pathology, Ragas Dental College and Hospital, Chennai, India

    17 shared publications
  • K Ranganathan

    Department of Oral and Maxillofacial Pathology, Ragas Dental College and Hospital, Uthandi, Chennai, Tamil Nadu, India

    13 shared publications
  • Umadevi Krishnamohan Rao

    Department of Oral and Maxillofacial Pathology, Ragas Dental College and Hospital, Chennai, India

    9 shared publications
  • Anusa Arunachalam Mohandoss

    Department of Psychiatry, Shri Sathya Sai Medical College and Research Institute, Affiliated to Sri Balaji Vidyapeeth, Deemed to be University, SBV Nagar, Chennai Campus, Tamil Nadu, 603108, India

    7 shared publications
  • Anusa Arunachalam Mohandoss

    Department of Psychiatry, Shri Sathya Sai Medical College and Research Institute, Affiliated to Sri Balaji Vidyapeeth, Deemed to be University, SBV Nagar, Chennai Campus, Ammapettai, Chengalpet Taluk, Kancheepuram, Nellikuppam, Tamil Nadu, India

    6 shared publications

Latest Publications

  • Open Access

    Mitigation of Mouth Opening in Oral Submucous Fibrosis with Nutraceutical Products: A Network Meta-Analysis

    by Anusa A. Mohandoss, Rooban Thavarajah, Elizabeth Joshua, Umadevi K. Rao

    Oral submucous fibrosis (OSF) is associated with habitual use of areca nut. Several nonsurgical interventions for OSF have been used, with increasing predilection to try plant-based products. The objective of the present study is to investigate the efficacy of nutraceutical products (NPs) and other classes of nonsurgical interventions in OSF management using the network meta-analysis (NMA) approach. After registering with PROSPERO, the present study systematically searched for relevant studies in databases. PICO framework was used to identify studies relevant to evaluate the effectiveness of NPs and other classes of interventions. Standard NMA tools were used to assess the quality of the included studies and perform analysis. A total of 51 studies were included for final analysis with 53 trials. The primary outcome of identified studies was the mean difference (MD) in mouth opening (MO) expressed as mean (95% confidence interval). There were 16 interventions including placebo involving 3850 patients. The highest MD is 10.14 (4.38–15.89) with steroids with/without spreading factor (SSF) with ultrasonography (USG), followed by 9.87 (2.96–16.78) with SSF and NP-systemic and USG application, while the least is 1.43 (-4.31 to 7.18) SSF (8.04%). The probability of placebo being the most effective intervention in MO is the highest (93.91%), followed by exercise (81.50%), as evidenced by Surface Under the Cumulative Ranking Curve (SUCRA) and litmus rank-o-gram. This NMA results, within its limitation, showed that several NP outcomes are statistically superior to placebo in improving the MO, but as a class of drugs, none of the classes exhibited supremacy over others, especially to placebo. The result of this NMA indicates that none of classes of non-surgical treatment, especially NPs, have no distinct advantage in mitigation MO in OSF treatment.


  • Open Access

    Effectiveness of areca nut and products containing areca nut cessation interventions: A network meta-analysis

    by Anusa Arunachalam Mohandoss, Rooban Thavarajah

    Introduction: Areca nut (AN) is the fourth commonly used psychoactive substance, some using it with tobacco (processed AN with tobacco [PANT]). AN–PANT predisposes to a myriad of health disorders. AN–PANT cessation strategies are modeled after tobacco cessation programs, and their efficacies are not evaluated critically. The present study aimed to assess the relative effectiveness of different AN–PANT cessation interventions using a nonparametric network meta-analysis (NMA). Material and Method: An NMA was conducted after registration with Prospero. A systematic search across PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases yielded 137 articles, with 29 duplicates removed. The study population, interventions, comparators, and outcomes framework guided selection criteria for ensuring a robust and relevant analysis. Result: In all, 11 interventions were evaluated across 9 studies involving 12,659 patients. The effect of cessation intervention, as an odds ratio with 95% credibility limits, ranged from 0.30 (0.022–4.01) for a type of behavioral intervention to 10.5 (0.62–229) for Escitalopram. The odds ratio of 95% credible interval of a few studies was only crossing 1. The risk of bias assessment demonstrated the extent of biases within the included trials, contributing to a comprehensive understanding of the wholesome evidence as of the end of 2023. Discussion: The present study underscores the urgent need to re-evaluate the study designs employed in AN/PANT addiction-cessation trials. The present evidence-based insights provided by this NMA could serve as a foundation for designing future trials and guiding clinical decision-making and policy development.


  • Open Access

    On hammer, nails, and researchers

    by Rooban Thavarajah

  • Morphologic changes in miniscrew implant after root contact and the mechanical risks of its reinsertion

    by Bebians Anselm Justhius Fabi, Valai Kasim Shakeel Ahmed, Nathamuni Rengarajan Krishnaswamy, Rooban Thavarajah


  • Open Access

    A COMPARATIVE ANALAYSIS OF INTER-SITE GENE EXPRESSION HETEROGENICITY OF NORMAL HUMAN BUCCAL MUCOSA WITH NORMAL GINGIVAL MUCOSA

    by Thavarajah Rooban, Kannan Ranganathan

    BACKGROUND Description of heterogeneity of gene expression of various human intraoral sites are not adequate. The aim of this study was to explore the difference of gene expression profiles of whole tissue obtained from apparently normal human gingiva and buccal mucosa (HGM, HBM). MATERIALS AND METHODS Gene sets fulfilling inclusion and exclusion criteria of HGM and HBM in gene Expression Omnibus(GEO) database were identified, segregated, filtered and analysed using the ExAtlas online web tool using pre-determined cut-off. The differentially expressed genes were studied for epithelial keratinization related, housekeeping(HKG), extracellular matrix related(ECMRG) and epithelial-mesenchymal transition related genes(EMTRGs). RESULTS In all 40 HBM and 64 HGM formed the study group. In all there were 18012 significantly expressed genes. Of this, 1814 were over-expressed and 1862 under-expressed HBM genes as compared to HGM. One in five of all studied genes significantly differed between HBM and HGM. For the keratinization genes, 1 in 6 differed. One of every 5 HKG-proteomics genes differed between HBM and HGM, while this ratio was 1-in 4 for all ECMRGs and EMTRGs. DISCUSSION This difference in the gene expression between the HBM and HGM could possibly influence a multitude of biological pathways. This result could explain partly the difference in clinicopathological features of oral lesions occurring in HBM and HGM. The innate genotypic difference between the two intra-oral niches could serve as confounding factor in genotypic studies. Hence studies that compare the HBM and HGM should factor-in these findings while evaluating their results.

  • Open Access

    Role of Efferocytosis in Oral Lichen Planus

    by Thavarajah Rooban, Kannan Ranganathan

    Background Oral lichen planus (OLP) is a chronic, immune mediated interface mucositis of oral mucosa. Though the apoptosis of keratinocytes is a feature of OLP, not much is known about the clearance of cell debris (efferocytosis) resulting from apoptosis. We postulate that there is a defective or delayed efferocytosis in OLP, which may have a role in modulating the immune response in OLP. Methods Published mRNA expression of tissue of 14 patients with OLP and 14 cases of normal tissues were subjected to differential analysis (DE) and a list of DE genes identified. From this list, the genes that involved in efferocytosis were collated, compared and their interactions are typed. Result In all, two studies fulfilled the inclusion and exclusion criteria. On combining the data, 1486 genes were significantly different between OLP and normal tissues. 28 of these 1486 genes are were associated with efferocytosis of which the suppression of LRP1, LDLR, ANAX2, C2, PBX1, PDCD4, S1PR5, CX3CL1, STAT6 and Wnt3A is indicative of defective or delayed efferocytosis in OLP. The role of pathways and associations were analyzed and is presented here. Discussion and Conclusion The study revealed that certain key genes mRNAs that are associated with efferocytosis are altered in OLP. They could delay or lead to defective efferocytosis. Studying such genes in detail could provide deeper understanding of the pathogenesis of the disease and the discovery of therapeutic targets.

  • Open Access

    Comparison of Ferroptosis Related Genes expression in Human Oral Squamous Cell Carcinoma and Normal oral tissues

    by Rooban Thavarajah, Elizabeth Joshua, Kannan Ranganathan

    Introduction Evasion of programmed cell death (PCD) is a hall mark of oncogenesis. There are different types of PCD. Iron related PCD, ferroptosis is being increasingly associated with neoplastic process. There are very few reports that investigate the role of ferroptosis in Oral Squamous Cell Carcinoma (OSCC). An attempt is made to compare the ferroptosis related genes(FRGs) expression in human OSCC and normal oral tissues. Materials and Methods Gene Expression Omnibus repository was scanned for OSCC mRNA datasets along with normal control tissues. Datasets fulfilling inclusion and exclusion criteria as well as that fulfilled the statistical correlation requirements were considered for this study. Differentially expressed mRNAs were identified. From the literature and ferroptosis database, FRGs were identified and those FRGs were differentially expressed were validated using The Human Cancer Genome dataset. Results In all 44 FRGs were identified to be differentially expressed between OSCC and control tissues. Of the 44, 21 were that promoted ferroptosis including 18 drivers of ferroptosis. Of the 21 FRGs that drives ferroptosis, 9 were found significantly elevated in controls while the remaining 12 were elevated in OSCC. The role of the differentially expressed FRGs were also studied. Of the 44 FRGs, 36 were validated using the human cancer genome dataset. Discussion and Conclusion Drivers and suppressors of ferroptosis were differentially expressed in OSCC and controls. This reflects that ferroptosis has a dual role in oncogenesis – both as a promoter and a suppressor. The identified specific FRGs in this studied would help to understand the role of PCD in OSCC progression and help in designing better treatment.

  • Open Access

    mRNA expression of ferroptosis-related proteins in squamous cell carcinoma of tongue

    by Rooban Thavarajah

    Objective: Glossal Squamous Cell Carcinoma (GSCC) has a distinct molecular profile including alterations in programed regulated cell death (RCD). Ferroptosis is a newly reported form of RCD mediated by ferric ions and mediated by several proteins. Till date, the possibility of this phenomenon in GSCC has not been explored.Materials and Methods: The proteins associated with ferroptosis were collated. The mRNA of corresponding proteins expression from GSCC lesional tissues and control tissues from the same patient from the human cancer genome project was obtained as raw values and subjected to differential expression (DE) analysis using DESeq2 statistics. The Benjamini and Hochberg (false discovery rate) approach was used to adjustP-value andP≤ 0.05 was set at statistical significance. Log fold change was set at 0.6. The significant genes were subjected to network analysis for protein-protein interaction and this network was analyzed for pathway enrichment analysis and presented.Results: There were 12 cases that had GSCC and controls (n= 12). There were 40 genes directly involved with ferroptosis and another 50 genes associated with the ferroptosis. Of this, 28 genes had DE, of which 16 genes were directly involved in the ferroptosis pathway and 12 genes associated with it. These genes, in enrichment analysis, indicated that the other pathways involved several other cancers and cancer signaling. Certain pro-ferroptotic genes and anti-ferroptotic genes had DE. Increase of PTGS2 and ACSL4 mRNA expression in GSCC tissue as compared to control was a significant finding. There is an increase of mRNA of genes that increase the ferric ions intracellularly. These findings would help to draw better and effective treatment strategies that can help to target neoplastic cells in GSCC.Conclusion: In GSCC, ferroptosis is a possibility and the differential expression of certain pro-ferroptotic genes could he harnessed to draw effective and safer treatment strategies.